Nippon Shinyaku Co Ltd ADR NPPNY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $6.84
- Day Range
- $6.93–6.93
- 52-Week Range
- $6.84–11.71
- Bid/Ask
- $6.83 / $6.90
- Market Cap
- $1.87 Bil
- Volume/Avg
- 117 / 808
Key Statistics
- Price/Earnings (Normalized)
- 10.46
- Price/Sales
- 1.76
- Dividend Yield (Trailing)
- 2.94%
- Dividend Yield (Forward)
- 2.94%
- Total Yield
- 2.94%
Company Profile
Nippon Shinyaku Co Ltd is a specialty and generic drug manufacturing company. Nippon's research and development activities include a focus on pharmaceuticals, nutraceuticals, safety and pharmacokinetics of drug seeds, genomic drug discovery, and nucleic acid drugs. The company also develops health food ingredients, preservatives, protein preparations, and spices. Nippon considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Core
- Total Number of Employees
- 2,186
- Website
- http://www.nippon-shinyaku.co.jp
Comparables
Valuation
|
Metric
|
NPPNY
|
4554
|
4577
|
|---|---|---|---|
Price/Earnings (Normalized) | 10.46 | 7.56 | 12.95 |
Price/Book Value | 1.21 | 0.90 | 0.76 |
Price/Sales | 1.76 | 0.91 | 0.87 |
Price/Cash Flow | 10.41 | 3.91 | 6.23 |
Price/Earnings
NPPNY
4554
4577
Financial Strength
|
Metric
|
NPPNY
|
4554
|
4577
|
|---|---|---|---|
Quick Ratio | 4.17 | 0.68 | 0.82 |
Current Ratio | 5.92 | 1.46 | 2.29 |
Interest Coverage | 256.02 | 55.27 | 197.65 |
Quick Ratio
NPPNY
4554
4577
Profitability
|
Metric
|
NPPNY
|
4554
|
4577
|
|---|---|---|---|
Return on Assets (Normalized) | 9.57% | 3.39% | 5.80% |
Return on Equity (Normalized) | 11.30% | 7.02% | 8.27% |
Return on Invested Capital (Normalized) | 10.97% | 4.22% | 7.32% |
Return on Assets
NPPNY
4554
4577
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Dngxcdwrf | Lbxmfy | $69.8 Bil | |
ZTS
| Zoetis Inc Class A | Hytzccbm | Xpw | $68.9 Bil | |
HLN
| Haleon PLC ADR | Xrkhxjjxk | Ynqv | $37.7 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Yyqkkpbq | Tyj | $14.8 Bil | |
VTRS
| Viatris Inc | Rngktznz | Lcf | $13.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Pfhsxszlx | Jnhz | $11.9 Bil | |
CTLT
| Catalent Inc | Hswqpxfvl | Gnjyjl | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Wlxfwdjc | Wfvyj | $4.2 Bil | |
CURLF
| Curaleaf Holdings Inc | Wcdzhlcs | Vsynb | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Smdszdqkc | Fsswk | $3.5 Bil |